Richard C. King
PharmCadence Analytical Services, LLC, USA

Dr. King graduated from SUNY College of Environmental Science and Forestry at Syracuse with a B.S. in Chemistry in 1986.  He obtained his Ph.D. in Analytical Chemistry from Drexel University in 1994 under the direction of Dr.  Kevin Owens.  The subject of his thesis was "MALDI TOFMS Instrumentation and Mechanisms".

He joined the Department of Drug Metabolism at Merck Research Laboratories, West Point, Pennsylvania in 1994 where he worked in Preclinical Drug Metabolism with responsibilities related to bioanalysis and new technology development and implementation until 2008.  In the fall of 2008 Dr. King became one of the founding members of PharmaCadence Analytical Services, LLC of Hatfield PA, a drug discovery analytical support CRO.

Dr. King’s research interests cover a number of key areas in quantitative analysis by mass spectrometry including, ion formation mechanisms, ion chemistry, data processing, separation science, and automation.